Loteprednol Etabonate Suspension/ Drops
Product Images NDC 62756-232

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 62756-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-loteprednol-carton (Spl Loteprednol Carton)

This is a description of a Sterile Ophthalmic Suspension medication containing Loteprednol Etabonate, with a concentration of 0.5%. The suspension is isotonic and contains benzalkonium chloride as a preservative. The medication should be shaken well before use and stored upright between 20°C-25°C. The usual dosage is not mentioned in this text. The medication is manufactured by Sun Pharmaceutical Medicare Ltd. in India and distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ. This medication is intended for ophthalmic use only.*

FDA Label Image

Spl-loteprednol-label (Spl Loteprednol Label)

This is a description of a medication called Loteprednol Etabonate Ophthalmic Suspension, used only for ophthalmic purposes. It contains Lotepredinol Etabonate as an active ingredient and is available in a 0.5% concentration. Each mL of the suspension has 5mg of the active ingredient. The medication should be stored upright at a temperature between 20°C-25°C, and should not be frozen. The NDC number for this medication is 62756-232-90. The rest of the text seems to be a logo or signature by two different pharmaceutical companies, and the may have misread these letters and numbers.*

FDA Label Image

Spl-loteprednol-structure (Spl Loteprednol Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.